ICGEB New Delhi - developments for Malaria Vaccine

With funding awarded under the Indian Department of Biotechnology and the European vaccine initiative, ICGEB New Delhi is developing a malaria vaccine


Virander Chauhan
, Director, ICGEB India, heads a research campaign to develop a malaria vaccine and bring it through the human trial stage.

 

Press Release:

July 2012
BioSpectrum Asia: Novavax, CPL Biologicals, ICGEB join hands for malaria research
Business Standard: Cadila Pharma, Novavax to develop malaria vaccine
Manufacturing Chemist: Novavax, CPL Biologicals and ICGEB to develop malaria vaccine
Pharmaceutical Business Review: Novavax, CPLB, ICGEB partner to develop malaria vaccine in India
FierceVaccines: Novavax teams up to fight malaria 

 

October 2011
Free Library online: Human trial of Indian malaria vaccine begins
India Today: ICGEB develops nation's first malaria vaccine

 

February 2011:
Biospectrum India: ICGEB cracks malaria puzzle: Is onto the first viable vaccine

Go back

Cod. Fisc. 90031700322

AREA Science Park
Padriciano 99
34149 Trieste, ITALY
Tel: +39-040-37571
Fax: +39-040-226555
icgebicgeb.org
Address book

 

 

 

 

 

 

 tl_files/iTunes_Badge_Color_master_10251024.png

 

tl_files/FB.png tl_files/Twitter_logo_blue-1def.png tl_files/rss.png
tl_files/LinkedIn-InBug-2CRev2.png tl_files/YouTube.png